These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33280004)

  • 1. Comment on: Onset of eosinophilic granulomatosis with polyangiitis in a patient treated with an IL-5 pathway inhibitor for severe asthma.
    Hočevar A; Kopač P; Rotar Ž; Plešivčnik Novljan M; Škrgat S
    Rheumatology (Oxford); 2021 Feb; 60(2):e78. PubMed ID: 33280004
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on: Onset of eosinophilic granulomatosis with polyangiitis in a patient treated with an IL-5 pathway inhibitor for severe asthma: reply.
    Caminati M; Maule M; Nalin F; Senna G; Lunardi C
    Rheumatology (Oxford); 2021 Feb; 60(2):e79-e80. PubMed ID: 33280054
    [No Abstract]   [Full Text] [Related]  

  • 3. Onset of eosinophilic granulomatosis with polyangiitis in a patient treated with an IL-5 pathway inhibitor for severe asthma.
    Caminati M; Maule M; Nalin F; Senna G; Lunardi C
    Rheumatology (Oxford); 2021 Feb; 60(2):e59-e60. PubMed ID: 32940680
    [No Abstract]   [Full Text] [Related]  

  • 4. Benralizumab as a glucocorticoid-sparing treatment option for severe asthma in eosinophilic granulomatosis with polyangiitis.
    Padoan R; Chieco Bianchi F; Marchi MR; Cazzador D; Felicetti M; Emanuelli E; Vianello A; Nicolai P; Doria A; Schiavon F
    J Allergy Clin Immunol Pract; 2020 Oct; 8(9):3225-3227.e2. PubMed ID: 32505716
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of Eosinophilic Granulomatosis with Polyangiitis: A Review.
    Raffray L; Guillevin L
    Drugs; 2018 Jun; 78(8):809-821. PubMed ID: 29766394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophilic granulomatosis with polyangiitis evolution during severe eosinophilic asthma treatment with benralizumab.
    Hočevar A; Kopač P; Rotar Ž; Novljan MP; Škrgat S
    J Allergy Clin Immunol Pract; 2020; 8(7):2448-2449. PubMed ID: 32304835
    [No Abstract]   [Full Text] [Related]  

  • 7. The Role of T Helper Type 2 (Th2) Cytokines in the Pathogenesis of Eosinophilic Granulomatosis with Polyangiitis (eGPA): an Illustrative Case and Discussion.
    Milne ME; Kimball J; Tarrant TK; Al-Rohil RN; Leverenz DL
    Curr Allergy Asthma Rep; 2022 Nov; 22(11):141-150. PubMed ID: 36103081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New-onset eosinophilic granulomatosis with polyangiitis in 2 patients during treatment with IL-5 pathway inhibitors.
    Holubar J; Arnaud E; Broner J; Pers YM; Proust A; Goulabchand R
    Immunol Res; 2022 Dec; 70(6):721-724. PubMed ID: 36125736
    [No Abstract]   [Full Text] [Related]  

  • 9. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) presenting as diffuse myositis.
    Parent ME; Larue S; Ellezam B
    BMC Musculoskelet Disord; 2014 Nov; 15():388. PubMed ID: 25414144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of omalizumab-associated eosinophilic granulomatosis with polyangiitis.
    Yamaki Y; Hayashi D; Honda K; Imai H; Takada H
    Pediatr Int; 2021 Sep; 63(9):1119-1121. PubMed ID: 34170601
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic immunomodulation in eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
    Puéchal X
    Joint Bone Spine; 2016 Jan; 83(1):7-10. PubMed ID: 26639221
    [No Abstract]   [Full Text] [Related]  

  • 12. Eosinophilic granulomatosis with polyangiitis successfully treated with benralizumab.
    Chica-Guzmán MV; Morillo-Guerrero R; Carrón-Herrero A; González-de-Olano D; Almonacid-Sánchez C
    Ann Allergy Asthma Immunol; 2020 Aug; 125(2):228-230. PubMed ID: 32407950
    [No Abstract]   [Full Text] [Related]  

  • 13. Omalizumab-associated eosinophilic granulomatosis with polyangiitis: cause or coincidence?
    Carson LN; Pradhan A; Subramanian D
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34326107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of eosinophilic granulomatosis with polyangiitis phenotypes and treatment based on phenotypes.
    Yılmaz İ; Türk M; Bahçecioğlu SN
    Autoimmun Rev; 2017 Sep; 16(9):992-993. PubMed ID: 28711579
    [No Abstract]   [Full Text] [Related]  

  • 15. Interleukin-5 inhibition in eosinophilic granulomatosis with polyangiitis: time for another approach?
    Gill B; Putman M
    Lancet Rheumatol; 2023 Dec; 5(12):e698-e699. PubMed ID: 38251556
    [No Abstract]   [Full Text] [Related]  

  • 16. An alternative approach against eosinophils for the treatment of eosinophilic granulomatosis with polyangiitis.
    Carrillo-Martin I; Abril A; Donaldson AM; Gonzalez-Estrada A
    J Allergy Clin Immunol Pract; 2020 Jun; 8(6):2079-2080. PubMed ID: 32006724
    [No Abstract]   [Full Text] [Related]  

  • 17. Eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): where are we now?
    Groh M; Pagnoux C; Guillevin L
    Eur Respir J; 2015 Nov; 46(5):1255-8. PubMed ID: 26521277
    [No Abstract]   [Full Text] [Related]  

  • 18. Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis.
    McBrien CN; Menzies-Gow A
    Drugs Today (Barc); 2018 Feb; 54(2):93-101. PubMed ID: 29637936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?
    Akdime F; Puéchal X; Roche N
    J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2942-2943. PubMed ID: 34246444
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acute myocardial infarction as Eosinophilic granulomatosis with polyangiitis (formerly Churg Strauss syndrome) initial presentation].
    Sulaiman W; Seung OP; Noor SM
    Rev Bras Reumatol; 2014; 54(5):393-6. PubMed ID: 25627304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.